297 related articles for article (PubMed ID: 35399566)
21. Integrative Multi-Omics Analysis of Identified NUF2 as a Candidate Oncogene Correlates With Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer.
Chen M; Li S; Liang Y; Zhang Y; Luo D; Wang W
Front Oncol; 2021; 11():656509. PubMed ID: 34178642
[TBL] [Abstract][Full Text] [Related]
22. NcRNA-Mediated High Expression of
Jiang X; Tang L; Yuan Y; Wang J; Zhang D; Qian K; Cho WC; Duan L
Front Oncol; 2022; 12():846536. PubMed ID: 35311097
[TBL] [Abstract][Full Text] [Related]
23. Downregulated Expression of CLEC9A as Novel Biomarkers for Lung Adenocarcinoma.
Miao F; Lou Z; Ji S; Wang D; Sun Y; Liu H; Yang C
Front Oncol; 2021; 11():682814. PubMed ID: 34616670
[TBL] [Abstract][Full Text] [Related]
24. FGL1 in plasma extracellular vesicles is correlated with clinical stage of lung adenocarcinoma and anti-PD-L1 response.
Zhang Y; Zhang K; Wen H; Ge D; Gu J; Zhang C
Clin Exp Immunol; 2024 Mar; 216(1):68-79. PubMed ID: 38146642
[TBL] [Abstract][Full Text] [Related]
25.
Xu T; Xu S; Yao Y; Chen X; Zhang Q; Zhao X; Wang X; Zhu J; Liu N; Zhang J; Lin Y; Zou J
J Thorac Dis; 2022 Feb; 14(2):515-535. PubMed ID: 35280459
[TBL] [Abstract][Full Text] [Related]
26. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
27. Immune-Related miRNA-195-5p Inhibits the Progression of Lung Adenocarcinoma by Targeting Polypyrimidine Tract-Binding Protein 1.
Duan L; Wang J; Zhang D; Yuan Y; Tang L; Zhou Y; Jiang X
Front Oncol; 2022; 12():862564. PubMed ID: 35600383
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of
Wei D; Sun D; Sirera R; Afzal MZ; Leong TL; Li X; Wang Y
Transl Lung Cancer Res; 2023 Jul; 12(7):1517-1538. PubMed ID: 37577299
[TBL] [Abstract][Full Text] [Related]
29. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH
World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904
[TBL] [Abstract][Full Text] [Related]
30. Decreased zinc-fingers and homeoboxes family expression was associated with unfavorable outcomes and immune infiltration in lung adenocarcinoma.
Tao D; Tan J; Zhang N; Yang D; Jiang Y; Zhou W; Wang Y; Wu Y
Transl Cancer Res; 2023 Jun; 12(6):1422-1440. PubMed ID: 37434685
[TBL] [Abstract][Full Text] [Related]
31. Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma.
Chen R; Wang Z; Lu T; Liu Y; Ji Y; Yu Y; Tou F; Guo S
Thorac Cancer; 2023 Apr; 14(10):893-912. PubMed ID: 36825773
[TBL] [Abstract][Full Text] [Related]
32. Cyclic adenosine monophosphate/phosphodiesterase 4 pathway associated with immune infiltration and PD-L1 expression in lung adenocarcinoma cells.
Tong L; Shan M; Zou W; Liu X; Felsher DW; Wang J
Front Oncol; 2022; 12():904969. PubMed ID: 35978822
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value and immune infiltration of the gasdermin family in lung adenocarcinoma.
Peng LS; Duan SL; Li RQ; Wang D; Han YY; Huang T; Yu YP; Ou CL; Wang JP
Front Oncol; 2022; 12():1043862. PubMed ID: 36505798
[TBL] [Abstract][Full Text] [Related]
34. FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer.
Sun C; Gao W; Liu J; Cheng H; Hao J
Respir Res; 2020 Aug; 21(1):210. PubMed ID: 32778129
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
[TBL] [Abstract][Full Text] [Related]
36. CBX7, a Potential Prognostic Biomarker in Lung Adenocarcinoma.
Yang Y; Hu Z; Sun H; Yu Q; Yang L; Yin F; Sun Y; Pu L; Zhu X; Li S; Chen X; Zhao Y
Onco Targets Ther; 2021; 14():5477-5492. PubMed ID: 34992383
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the Prognostic Value of STEAP1 in Lung Adenocarcinoma and Insights Into Its Potential Molecular Pathways via Bioinformatic Analysis.
Guo Q; Ke XX; Liu Z; Gao WL; Fang SX; Chen C; Song YX; Han H; Lu HL; Xu G
Front Genet; 2020; 11():242. PubMed ID: 32265985
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the Oncogene Function of GOLPH3 and Correlated Regulatory Network in Lung Adenocarcinoma.
Zhang T; Wang Y; Chen Y; Jin S; Gao Y; Zhang D; Wu Y
Front Oncol; 2021; 11():669684. PubMed ID: 34497755
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
40. MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma.
Li M; Ren H; Zhang Y; Liu N; Fan M; Wang K; Yang T; Chen M; Shi P
Front Oncol; 2022; 12():772686. PubMed ID: 35174083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
